药房抢劫和职业安全风险:社区药房的全国横截面研究
Mohanad Odeh1, Dana M Odeh2, Enas Alkhader3
1Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, P.O. Box 330127, Zarqa 13133, Jordan.
Exploratory research in clinical and social pharmacy
|March 2, 2026
概括
药房抢劫事件没有得到充分研究,4.3%的药剂师报告暴露. 关键的风险因素包括深夜工作,单一的员工和分发麻醉品,突出了提高安全和培训的必要性.
科学领域:
- 药房实践 在药房实践.
- 公共卫生 公共卫生
- 犯罪学 犯罪学
背景情况:
- 社区药房经历了大量的工作场所暴力,但药房抢劫事件的研究不足,特别是在中东.
- 关于约旦和周边地区药店抢劫的流行率和风险因素,存在一个关键的研究缺口.
研究的目的:
- 量化社区药房遭受抢劫的情况.
- 识别与抢劫有关的药房级感知风险因素.
- 为了比较经历过抢劫的药剂师与没有经历过抢劫的药剂师之间的风险感知.
主要方法:
- 通过使用自我管理的问卷进行了分析性的横截面调查,其内容有效性和内部一致性得到了验证.
- 分析了975名药剂师的数据,使用克莱默的V和多变量逻辑回归的奇平方测试.
- 在收集数据之前,从机构审查委员会获得了道德批准.
主要成果:
- 4.3%的受访者报告被抢劫,男性和30岁以上的药剂师的比例更高.
- 最常被引用的药房级别风险因素包括延迟开业时间 (81.2%),单一人员 (77.3%),分发麻醉品 (77.2%),缺乏监控摄像头 (72.6%).
- 与犯罪者相关的个人因素和以前与侵略性客户的经验是抢劫暴露的显著独立相关因子.
结论:
- 抢劫,攻击性客户行为和危险遭遇在社区药房中构成重大风险.
- 暴露和未暴露药剂师之间的感知风险因素的差异,以及犯罪者和行为因素的影响,需要基于证据的安全政策.
- 建议包括实施最低人事标准,并提供培训,以识别和管理高风险的客户互动,以减轻抢劫风险.
更多相关视频
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
2.1K
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.5K
相关概念视频
01:26Pharmaceutical Poisoning: Potential Scenarios
47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
01:24Drug Toxicity: Risk factors
61
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
61
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
229
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
229
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
388
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388